Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Delirium 1

Interventions

Carboplatin 1152Cisplatin 876Pemetrexed 834pembrolizumab 608Paclitaxel 598Docetaxel 535Gemcitabine 424Radiotherapy 377Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 295durvalumab 254Drug Therapy 233osimertinib 218atezolizumab 208Radiosurgery 190Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 124Magnetic Resonance Spectroscopy 121Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × flurbiprofen axetil × Thoracic × Clear all
NCT03200600 2021-07-13

Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery

Peking University First Hospital

Phase 4 Terminated
126 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Delirium

NCT03172988 2019-03-05

Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery

Peking University First Hospital

Phase 4 Terminated
126 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡